Corrigendum to “Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation” [Eur J Cancer 57 (April 2016) 118–126]

Laurys Boudin (1) , Christian Chabannon (2) , Patrick Sfumato (2) , Renaud Sabatier (2) , François Bertucci (2) , Carole Tarpin (3) , Magali Provansal (1) , Gilles Houvenaeghel (4) , Eric Lambaudie (2) , Agnes Tallet (5) , Michel Resbeut (5) , Emmanuelle Charafe-Jauffret (2) , Boris Calmels (2) , Claude Lemarie (6) , Jean-Marie Boher (4) , Jean-Marc Extra (1) , Patrice Viens (2) , Anthony Gonçalves (7)

1 Département d’Oncologie médicale [IP-C, Marseille]
2 CRCM - Centre de Recherche en Cancérologie de Marseille
3 Département d’Oncologie Médicale [Marseille]
4 IPC - Institut Paoli-Calmettes
5 Département de Radiothérapie [IP-C, Marseille]
6 CIC - Biotherapie - Marseille
7 Service d'Oncologie Médicale [Marseille]

Domaines: Cancer

Laurys Boudin, Christian Chabannon, Patrick Sfumato, Renaud Sabatier, François Bertucci, et al.. Corrigendum to “Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation” [Eur J Cancer 57 (April 2016) 118–126]. European Journal of Cancer, 2016, 67, pp.223. ⟨10.1016/j.ejca.2016.09.002⟩. ⟨hal-03623727⟩